Description: Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India. The company's product portfolio consists of various APIs in the therapeutic categories of nutraceutical (amino acids), vitamins, anti-convulsants, bactericidal and bacteriostatic, diuretic and vasodilator, mineral and nutritional supplements, bronchodilater/anti-asthmatic, and nootropics. Its finished dosage formulations cover various therapeutic segments, such as antibiotics, anti-arrhythmia, anti-convulsants, anti-diabetes, anti-platelets, NSAIDs, vitamins and its derivatives, anti-hypertensive, anti-bacterial, anti-malarial, cholinesterase inhibitors, etc. The company manufactures formulations in the form of tablets, capsules, and sachets under its brands, as well as for other pharmaceutical companies on a loan license basis. It also exports its products to Europe, the United States, Australia, Africa, South America, etc. Bajaj HealthCare Limited was founded in 1993 and is based in Thane, India.
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 17.1201 |
| Price-to-Book MRQ: | 3.2736 |
| Price-to-Sales TTM: | 1.6326 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 666 |